To determine whether AKT signaling is critical for 3-HAA regulation on stemness of HCC cells, the AKT activator (SC79) was applied to investigate the effect of AKT activation on GSK-3β/β-catenin signaling. The gene discussed is GSK3B; the disease is hepatocellular carcinoma.